• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MRI上的LI-RADS分类与肝内胆管癌术后复发相关:一项多中心研究

LI-RADS Category on MRI Is Associated With Recurrence of Intrahepatic Cholangiocarcinoma After Surgery: A Multicenter Study.

作者信息

Hwang Jeong Ah, Lee Sunyoung, Lee Ji Eun, Yoon Jongjin, Choi Seo-Yeon, Shin Jaeseung

机构信息

Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.

出版信息

J Magn Reson Imaging. 2023 Mar;57(3):930-938. doi: 10.1002/jmri.28354. Epub 2022 Jul 14.

DOI:10.1002/jmri.28354
PMID:35833798
Abstract

BACKGROUND

The Liver Imaging Reporting and Data System (LI-RADS) is a comprehensive system for standardizing the terminology and interpretation of liver imaging. The association between the LI-RADS category and tumor recurrence in patients with intrahepatic cholangiocarcinomas (iCCAs) has not yet been evaluated in a multicenter study.

PURPOSE

To retrospectively investigate the preoperative clinical and imaging features associated with recurrence-free survival (RFS) after curative resection of iCCAs and to identify the role of the LI-RADS category in at-risk patients.

STUDY TYPE

Retrospective, multicenter.

SUBJECTS

A total of 113 patients (mean age: 61.1 years; 74 men, 39 women) who underwent preoperative contrast-enhanced MRI and curative surgical resection for a single treatment-naive iCCA between 2008 and 2021.

FILED STRENGTH/SEQUENCE: A 3 T dual gradient-echo T WI with in- and opposed-phase, turbo spin-echo T WI, diffusion-weighted echo-planar images, and three-dimensional gradient-echo T WI before and after administration of contrast agent.

ASSESSMENT

MR imaging features were evaluated and assigned for each lesion using LI-RADS version 2018. RFS was calculated from the date of surgery to tumor recurrence or the last imaging date without evidence of recurrence. Factors affecting RFS were evaluated using clinical and imaging features.

STATISTICAL TESTS

Cox proportional hazards model, Kaplan-Meier method, and log-rank test. A P-value of <0.05 was considered statistically significant.

RESULTS

A total of 93 (82.3%) were categorized as LR-M and 20 (17.7%) were categorized as LR-4 or 5. In the multivariable analysis, LR-M category (hazard ratio [HR], 8.035; 95% confidence interval [CI], 1.096-58.931) and a tumor size >3 cm on MRI (HR, 2.690; 95% CI, 1.319-5.487) were independent factors for poor RFS. The 5-year RFS rate was significantly higher in patients with iCCA categorized as LR-4 or 5 than in those categorized as LR-M (94.4% vs. 51.9%, respectively).

DATA CONCLUSION

Patients with iCCA categorized as LR-4 or 5 may have a better RFS than those categorized as LR-M.

EVIDENCE LEVEL

3 TECHNICAL EFFICACY: Stage 2.

摘要

背景

肝脏影像报告和数据系统(LI-RADS)是一个用于规范肝脏影像术语和解读的综合系统。肝内胆管癌(iCCA)患者的LI-RADS分类与肿瘤复发之间的关联尚未在多中心研究中得到评估。

目的

回顾性研究iCCA根治性切除术后与无复发生存期(RFS)相关的术前临床和影像特征,并确定LI-RADS分类在高危患者中的作用。

研究类型

回顾性、多中心研究。

研究对象

2008年至2021年间,共有113例患者(平均年龄:61.1岁;男性74例,女性39例)因初治的单发iCCA接受了术前对比增强MRI和根治性手术切除。

场强/序列:3T双梯度回波T1WI同反相位成像、快速自旋回波T2WI、扩散加权回波平面成像以及注射对比剂前后的三维梯度回波T1WI。

评估

使用2018版LI-RADS对每个病灶的MR成像特征进行评估和分类。RFS从手术日期计算至肿瘤复发或无复发证据的最后一次成像日期。使用临床和影像特征评估影响RFS的因素。

统计检验

Cox比例风险模型、Kaplan-Meier法和对数秩检验。P值<0.05被认为具有统计学意义。

结果

共有93例(82.3%)被分类为LR-M,20例(17.7%)被分类为LR-4或5。在多变量分析中,LR-M分类(风险比[HR],8.035;95%置信区间[CI],1.096-58.931)和MRI上肿瘤大小>3 cm(HR,2.690;95%CI,1.319-5.487)是RFS不良的独立因素。iCCA分类为LR-4或5的患者5年RFS率显著高于分类为LR-M的患者(分别为94.4%和51.9%)。

数据结论

iCCA分类为LR-4或5的患者可能比分类为LR-M的患者具有更好的RFS。

证据水平

3级 技术效能:2级

相似文献

1
LI-RADS Category on MRI Is Associated With Recurrence of Intrahepatic Cholangiocarcinoma After Surgery: A Multicenter Study.MRI上的LI-RADS分类与肝内胆管癌术后复发相关:一项多中心研究
J Magn Reson Imaging. 2023 Mar;57(3):930-938. doi: 10.1002/jmri.28354. Epub 2022 Jul 14.
2
Characteristics and Early Recurrence of Hepatocellular Carcinomas Categorized as LR-M: Comparison with Those Categorized as LR-4 or 5.LR-M 型肝癌的特征和早期复发:与 LR-4 或 5 型肝癌的比较。
J Magn Reson Imaging. 2021 Nov;54(5):1446-1454. doi: 10.1002/jmri.27650. Epub 2021 Apr 23.
3
Comparing Survival Outcomes of Patients With LI-RADS-M Hepatocellular Carcinomas and Intrahepatic Cholangiocarcinomas.比较LI-RADS-M型肝细胞癌和肝内胆管癌患者的生存结果。
J Magn Reson Imaging. 2023 Jan;57(1):308-317. doi: 10.1002/jmri.28218. Epub 2022 May 5.
4
Combined Hepatocellular-Cholangiocarcinoma: Magnetic Resonance Imaging Features and Prognosis According to Risk Factors for Hepatocellular Carcinoma.混合型肝细胞癌:基于肝细胞癌危险因素的磁共振成像特征和预后。
J Magn Reson Imaging. 2021 Jun;53(6):1803-1812. doi: 10.1002/jmri.27528. Epub 2021 Feb 9.
5
Combined hepatocellular-cholangiocarcinoma: can we use contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) to predict the patient's survival?肝细胞癌-胆管细胞癌混合型:我们能否使用增强超声肝脏影像报告与数据系统(LI-RADS)来预测患者的生存情况?
Eur Radiol. 2021 Aug;31(8):6397-6405. doi: 10.1007/s00330-020-07656-1. Epub 2021 Jan 25.
6
Clinicopathologic and MRI features of combined hepatocellular-cholangiocarcinoma in patients with or without cirrhosis.伴有或不伴有肝硬化的肝细胞癌-胆管细胞癌患者的临床病理和 MRI 特征。
Liver Int. 2021 Jul;41(7):1641-1651. doi: 10.1111/liv.14798. Epub 2021 Feb 13.
7
Risk stratification of LI-RADS M and LI-RADS 4/5 combined hepatocellular cholangiocarcinoma: prognostic values of MR imaging features and clinicopathological factors.LI-RADS M 和 LI-RADS 4/5 型合并肝细胞癌的风险分层:MR 成像特征和临床病理因素的预后价值。
Eur Radiol. 2022 Aug;32(8):5166-5178. doi: 10.1007/s00330-022-08691-w. Epub 2022 Mar 22.
8
Prognostic value of LI-RADS category on gadoxetic acid-enhanced MRI and 18F-FDG PET-CT in patients with primary liver carcinomas.LI-RADS 类别在钆塞酸增强 MRI 和 18F-FDG PET-CT 对原发性肝癌患者的预后价值。
Eur Radiol. 2021 Jun;31(6):3649-3660. doi: 10.1007/s00330-020-07378-4. Epub 2020 Nov 19.
9
Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance?肝细胞癌-胆管细胞癌混合型:哪些术前临床资料和常规 MRI 特征对微血管侵犯的预测有价值及其临床意义?
Eur Radiol. 2020 Oct;30(10):5337-5347. doi: 10.1007/s00330-020-06861-2. Epub 2020 May 8.
10
Liver Imaging Reporting and Data System Category on Magnetic Resonance Imaging Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation Within the Milan Criteria: A Multicenter Study.磁共振成像 Liver Imaging Reporting and Data System 分类预测米兰标准内肝移植后肝细胞癌复发:一项多中心研究。
Ann Surg Oncol. 2021 Oct;28(11):6782-6789. doi: 10.1245/s10434-021-09772-8. Epub 2021 Mar 9.

引用本文的文献

1
An oxidative stress related gene signature predicts prognosis in cholangiocarcinoma.一种与氧化应激相关的基因特征可预测胆管癌的预后。
Discov Oncol. 2025 Aug 18;16(1):1576. doi: 10.1007/s12672-025-03434-x.
2
LR-M for CT/MRI on LI-RADS v2018: a review of imaging criteria, performance, challenges and future directions from an end-user perspective.基于LI-RADS v2018的CT/MRI肝脏报告和数据系统:从终端用户角度对成像标准、性能、挑战及未来方向的综述
Abdom Radiol (NY). 2025 Aug 14. doi: 10.1007/s00261-025-05132-2.
3
Assessment of intrahepatic cholangiocarcinoma with LI-RADS in the high-risk population: MRI diagnosis and postoperative survival.
高危人群中使用肝脏影像报告和数据系统(LI-RADS)评估肝内胆管癌:MRI诊断及术后生存情况
Cancer Imaging. 2025 Mar 26;25(1):40. doi: 10.1186/s40644-025-00860-6.
4
LI-RADS Category Can Be a Post-Surgical Prognostic Factor for Intrahepatic Cholangiocarcinoma in Patients with Liver Cirrhosis or Chronic Hepatitis B.肝脏影像报告和数据系统(LI-RADS)分类可作为肝硬化或慢性乙型肝炎患者肝内胆管癌的术后预后因素。
Liver Cancer. 2024 Jun 14;13(6):629-642. doi: 10.1159/000539794. eCollection 2024 Dec.
5
Inter-reader agreement for CT/MRI LI-RADS category M imaging features: a systematic review and meta-analysis.CT/MRI肝脏影像报告和数据系统(LI-RADS)M类成像特征的阅片者间一致性:一项系统评价和Meta分析
J Liver Cancer. 2024 Sep;24(2):192-205. doi: 10.17998/jlc.2024.04.05. Epub 2024 Apr 15.